Company intelligence / Profile preview

Cyanotech

Kailua-Kona, Hawaii, United Statescyanotech.com ↗

Ownership: Private
Development stage: Other

Overview

Cyanotech produces and markets two main microalgae-derived products—BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica—which are the leading brands in their categories in the U.S. Both have been commercialized for years as dietary supplements with established safety profiles. No clinical trial data or prescription drug development programs reported.

Therapeutic areas: DermatologyOphthalmologyOtherImmunologyRheumatology
Modalities: Protein (spirulina)Small molecule (astaxanthin carotenoid antioxidant)Natural product
Industry: Food & Nutrition

Beyond the preview

Go deeper on Cyanotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyanotech.

Explore the full profile